What is Zacks Research’s Estimate for DLB FY2026 Earnings?

Dolby Laboratories (NYSE:DLBFree Report) – Zacks Research boosted their FY2026 earnings estimates for shares of Dolby Laboratories in a research report issued to clients and investors on Thursday, August 20th. Zacks Research analyst Team now forecasts that the electronics maker will post earnings per share of $3.17 for the year, up from their previous forecast of $3.16. The consensus estimate for Dolby Laboratories’ current full-year earnings is $3.26 per share.

Dolby Laboratories (NYSE:DLBGet Free Report) last issued its quarterly earnings data on Thursday, July 30th. The electronics maker reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The firm had revenue of $305.00 million during the quarter, compared to the consensus estimate of $311.96 million. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The company’s revenue for the quarter was down 3.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.78 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS.

DLB has been the subject of several other research reports. Rosenblatt Securities restated a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a research report on Friday, July 31st. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday, June 15th. Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Finally, Weiss Ratings downgraded Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, August 13th. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $83.00.

Read Our Latest Report on DLB

Dolby Laboratories Stock Performance

NYSE DLB opened at $66.27 on Wednesday. The company has a market capitalization of $6.21 billion, a PE ratio of 28.20 and a beta of 0.80. The business’s fifty day moving average is $55.01 and its 200 day moving average is $58.51. Dolby Laboratories has a fifty-two week low of $48.26 and a fifty-two week high of $74.62.

Institutional Trading of Dolby Laboratories

Several institutional investors have recently made changes to their positions in DLB. Bank of New York Mellon Corp bought a new stake in Dolby Laboratories during the 2nd quarter valued at approximately $253,289,000. California State Teachers Retirement System grew its holdings in Dolby Laboratories by 5,009.3% during the 2nd quarter. California State Teachers Retirement System now owns 3,705,155 shares of the electronics maker’s stock valued at $194,817,000 after buying an additional 3,632,637 shares in the last quarter. State Street Corp raised its position in shares of Dolby Laboratories by 8.7% during the second quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after buying an additional 180,072 shares during the last quarter. First Trust Advisors LP raised its position in shares of Dolby Laboratories by 19.9% during the first quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock valued at $135,431,000 after buying an additional 374,405 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Dolby Laboratories by 15.6% during the fourth quarter. Geode Capital Management LLC now owns 1,885,246 shares of the electronics maker’s stock valued at $122,749,000 after buying an additional 254,250 shares during the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Insider Activity at Dolby Laboratories

In related news, SVP Shriram Revankar sold 3,000 shares of the company’s stock in a transaction on Friday, August 14th. The shares were sold at an average price of $62.71, for a total value of $188,130.00. Following the completion of the transaction, the senior vice president owned 73,274 shares of the company’s stock, valued at approximately $4,595,012.54. This represents a 3.93% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP John D. Couling sold 7,667 shares of the stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $60.00, for a total value of $460,020.00. Following the completion of the sale, the senior vice president owned 118,727 shares of the company’s stock, valued at $7,123,620. The trade was a 6.07% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 27,705 shares of company stock worth $1,587,692. 37.93% of the stock is owned by corporate insiders.

Dolby Laboratories declared that its board has approved a stock repurchase program on Thursday, July 30th that authorizes the company to repurchase $350.00 million in outstanding shares. This repurchase authorization authorizes the electronics maker to buy up to 7% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s board believes its shares are undervalued.

Dolby Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 19th. Investors of record on Tuesday, August 11th were paid a dividend of $0.36 per share. The ex-dividend date was Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.2%. Dolby Laboratories’s payout ratio is 61.28%.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Further Reading

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.